Skip to main content

Table 1 Characteristics of the studies included in the review

From: The effect of therapies on the quality of life of patients with systemic lupus erythematosus: a meta-analysis of randomized trials

Author year

Population

Intervention

Follow-up

Outcome

Result

Abrahão, 2015 [6]

42

Intervention (n = 21)

cardiovascular training

Control group (n = 21)

(usual care and information about the disease)

03 months

Quality of life

The intervention group presented a significant improvement in the physical health and vitality aspect, in the general health aspect no significant differences were found (SF36 health survey questionnaire)

Arriens, 2015 [9]

32

Intervention (n = 18)

(supplementation with fish oil)

Control group (n = 14)

(placebo)

06 months

Quality of life

The intervention group presented a significant improvement in the mental health and vitality aspect (SF36 health survey questionnaire)

Boström, 2016 [7]

31

Intervention (n = 17)

(physical activity)

Control group (n = 14)

(usual care)

12 months

Quality of life

The intervention group had improved mental health, there was no significant improvement in the general health aspect (SF36 health survey questionnaire).

Navarrete, 2010 [4]

45

Intervention (n = 21)

(cognitive behavioral therapy)

Control group (n = 24)

(health care, moderate exercise, balanced diet and plenty of rest)

15 months

Quality of life

The intervention group had a significant reduction in the level of depression, anxiety and daily stress and a significant improvement in QoL and somatic symptoms (SF36 health survey questionnaire).

Navarrete et al, 2010 [8]

34

Intervention (n = 18)

cognitive behavioral therapy

Control group (n = 16)

(usual care)

15 months

Quality of life

The intervention group presented improvement in the level of physical function, vitality, general health perception andmental health (SF36 health survey questionnaire).

Shamehki, 2017 [5]

68

Intervention (n = 32)

(supplementation of green tea extract)

Control group (n = 36)

(placebo)

03 months

Quality of life

The intervention group presented a significant increase in hrvitality and general health (SF36 health survey questionnaire).

Strand, 2013 [10]

48

Intervention (n = 11)

(epratuzumab 720 mg/m2)

Control group (n = 37)

(placebo)

12 months

Quality of life

The intervention group showed evident improvements in the mean SF-36 scores (SF36 health survey questionnaire).